Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06019195 · ClinicalTrials.gov registry record · NA
The Effect of Intermittent Fasting on Brain Health
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06019195 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 32 participants.
The verdict
NCT06019195, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The central hypothesis of this study is that closer adherence to time restricted eating (TRE) will improve endothelial function, neurovascular (NVC) responses, resulting in improved cognitive performance, potentially through activation of SIRT1-dependent vasoprotective pathways.
Interventions
- OTHER Time restricted eating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-05-13 |
| Est. Completion | 2026-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06019195
The ClinicalTrials.gov registry entry for NCT06019195 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Time restricted eating is the first listed.
NCT06019195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06019195 about?
NCT06019195 is a clinical study titled "The Effect of Intermittent Fasting on Brain Health". The central hypothesis of this study is that closer adherence to time restricted eating (TRE) will improve endothelial function, neurovascular (NVC) responses, resulting in improved cognitive performance, potentially through activation of SIRT1-dependent vasoprotective pathways.
What is the current status of trial NCT06019195?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2024-05-13. Estimated completion is 2026-02-02.
What interventions are being tested in trial NCT06019195?
The interventions under investigation include: Time restricted eating (OTHER).
Who is sponsoring clinical trial NCT06019195?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.